Sheng Zhao
-
- Radiomics and Machine Learning in Medical Imaging 13
- MRI in cancer diagnosis 4
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 7
-
- Cancer Immunotherapy and Biomarkers 5
- Colorectal Cancer Surgical Treatments 4
- Peptidase Inhibition and Analysis 4
- Pharmaceutical Science top 10%
-
- Renal cell carcinoma treatment 7
-
- Advanced X-ray and CT Imaging 4
- Journals
- Nature Communications (1 paper)Journal of Clinical Oncology (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Sheng Zhao
46 papers receiving 595 citations
Peers
Comparison fields: 5 of 84
- Radiology, Nuclear Medicine and Imaging 174
- Cancer Research 111
- Hepatology 58
- Oncology 159
- Pharmaceutical Science 28
Countries citing papers authored by Sheng Zhao
This map shows the geographic impact of Sheng Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Zhao more than expected).
Fields of papers citing papers by Sheng Zhao
This network shows the impact of papers produced by Sheng Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Zhao. The network helps show where Sheng Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sheng Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 15 | |
| 3 | 2023 | 18 | |
| 4 | 2023 | 20 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 3 | |
| 11 | 2022 | 10 | |
| 12 | 2021 | 45 | |
| 13 | 2021 | 20 | |
| 14 | 2020 | 2 | |
| 15 | 2020 | 69 | |
| 16 | 2018 | 1 | |
| 17 | 2016 | 24 | |
| 18 | 2016 | 3 | |
| 19 | 2011 | 33 | |
| 20 | 2009 | 25 |
About Sheng Zhao
Sheng Zhao is a scholar working on Hepatology, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 48 papers that have together received 601 indexed citations. Recurring topics across this work include Radiomics and Machine Learning in Medical Imaging (13 papers), Renal cell carcinoma treatment (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), MRI in cancer diagnosis (4 papers), Colorectal Cancer Surgical Treatments (4 papers), Peptidase Inhibition and Analysis (4 papers) and Advanced X-ray and CT Imaging (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (174 citations), Cancer Research (111 citations) and Hepatology (58 citations). Sheng Zhao has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Huijie Jiang, Hao Jiang, Jinping Li, Huijie Jiang, Tao Sheng, Yuqi Zhang, Zhen Gu, Jicheng Yu, Shenqiang Wang and Jing Zhao. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.